SCHEMBL18040352

SCHEMBL18040352

OCC1CCCCN1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.41
CHRM2 P08172 4/20 0.41
CHRM1 P11229 4/20 0.41
CHRM3 P20309 3/20 0.41
KCNH2 Q12809 3/20 0.41
KMT2A Q03164 3/20 0.41
CHRM4 P08173 2/20 0.41
CHRM5 P08912 2/20 0.41
MEN1 O00255 2/20 0.41
HTR1A P08908 2/20 0.41
OPRM1 P35372 2/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
HRH1 P35367 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18040350 1.00 CYP2D6 (0.41) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL17923208 1.00 CYP2D6 (0.41) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL29182460 0.98 CHRM2 (0.43) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL29182446 0.98 CHRM2 (0.43) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL29182441 0.98 CHRM2 (0.43) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL7839730 0.95 MEN1 (0.46) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL9015291 0.95 MEN1 (0.46) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL25338317 0.88 MEN1 (0.38) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL20595815 0.88 MEN1 (0.38) CYP2D6CHRM2CHRM1CHRM3KCNH2
SCHEMBL29182442 0.88 MEN1 (0.38) CYP2D6CHRM2CHRM1CHRM3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016144241-A1 THERAPEUTIC USE OF ISOMERIC FORMS OF 2-(4-CHLOROPHENYL)QUINOLIN-4-YL)(PIPERIDIN-2-YL)METHANOL GLIONOVA AB (SE) 2016-09-15 WO disclosed
EP-3064205-A1 Therapeutic use of isomeric forms of 2-(4-chlorophenyl)quinolin-4-yl)(piperidin-2-yl)methanol Glionova AB (SE) 2016-09-07 EP disclosed